Skip to main content
Fig. 1 | Cancer Nanotechnology

Fig. 1

From: Dual enhancement in the radiosensitivity of prostate cancer through nanoparticles and chemotherapeutics

Fig. 1

Schematic figure outlining the strategy of the triple combination of gold nanoparticles (GNPs), docetaxel (DTX), and radiotherapy (RT). Both GNPs and DTX sensitize cells to radiation, amplifying the dose delivered, which can result in the enhancement of radiotherapeutic damage induced to tumor cells. Efficacy of treatment strategy was examined on both in vitro and in vivo prostate models. (Created using Biorender.com)

Back to article page